Lieff Cabraser Heimann & Bernstein, LLP
Active· since Feb 2, 2026
- 225
- days running
- 0
- relaunches
Ad copy
Did you or a family member use Dupixent® and later develop T-cell lymphoma? Learn your rights.
🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
